Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,246 | 154,758 | 109,931 | 61,904 | 74,357 |
| Marketable Securities | 396,259 | 337,204 | 361,293 | 455,416 | 477,872 |
| TOTAL | $473,454 | $502,101 | $481,465 | $528,824 | $569,061 |
| Non-Current Assets | |||||
| PPE Net | 102,826 | 106,386 | 109,849 | 112,839 | 114,442 |
| Investments And Advances | 37,535 | 62,496 | 53,912 | 76,468 | 99,154 |
| Other Non-Current Assets | 98,511 | 99,988 | 101,645 | 103,448 | 104,915 |
| TOTAL | $238,872 | $268,870 | $265,406 | $292,755 | $318,511 |
| Total Assets | $712,326 | $770,971 | $746,871 | $821,579 | $887,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,205 | 10,229 | 14,688 | 13,890 | 11,045 |
| Accrued Expenses | 31,195 | 44,263 | 44,624 | 39,743 | 36,938 |
| TOTAL | $37,636 | $54,721 | $59,585 | $53,728 | $48,872 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 236 | 229 | 273 | 95 | 889 |
| Other Non-Current Liabilities | 91,588 | 93,344 | 95,024 | 100,969 | 98,739 |
| TOTAL | $91,588 | $93,344 | $95,024 | $100,969 | $98,739 |
| Total Liabilities | $129,224 | $148,065 | $154,609 | $154,697 | $147,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 168,277 | 167,626 | 145,842 | 144,497 | 144,210 |
| Common Shares | 168 | 167 | 146 | 144 | 144 |
| Retained earnings | -1,473,988 | -1,412,673 | -1,334,684 | -1,234,968 | -1,141,133 |
| Other shareholders' equity | -2,411 | -3,851 | -5,934 | -9,926 | -12,958 |
| TOTAL | $583,102 | $622,906 | $592,262 | $666,882 | $739,961 |
| Total Liabilities And Equity | $712,326 | $770,971 | $746,871 | $821,579 | $887,572 |